REPORTS

Let’s Pullulate and Expand Your Business

Non-Invasive Prenatal Testing Devices Market - Global Professional Analysis and Forecast to 2026

Oct 13, 2019  |  179 PAGES  |  REPORT CODE: CMM208438
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Non-Invasive Prenatal Testing Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.9% during the forecast period.

This report presents the market size and development trends by detailing the Non-Invasive Prenatal Testing Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Non-Invasive Prenatal Testing Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Non-Invasive Prenatal Testing Devices industry and will help you to build a panoramic view of the industrial development.

Non-Invasive Prenatal Testing Devices Market, By Type:

  • Panorama Test

  • MaterniT21 Plus Test

  • Harmony Test

  • NIFTY Test

  • Verifi Test

  • IONA Test

  • Prena Test

  • Veracity Test

Non-Invasive Prenatal Testing Devices Market, By Application:

  • Hospitals

  • Clinics

  • Research Laboratories

Some of the leading players are as follows:

  • Safembryo

  • Beijing Genomics Institute

  • PerkinElmer, Inc

  • NIPD Genetics

  • Laboratory Corporation of America Holdings

  • California, Inc

  • GE Healthcare

  • Ariosa Diagnostics (Roche)

  • Natera

  • LifeLabs Genetics

  • Berry Genomics

  • Illumina, Inc

  • Agilent Technologies, Inc

  • Genpharm Services

  • Quest Diagnostics

  • LifeCodexx AG

  • F. Hoffmann-La Roche

  • QIAGEN N.V

  • Sengenics

  • Koninklijke Philips N.V

  • Premaitha Health PLC

  • Sequenom

  • Thermo Fisher Scientific, Inc

  • CombiMatrix

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Non-Invasive Prenatal Testing Devices Market: Technology Type Analysis

  • 4.1 Non-Invasive Prenatal Testing Devices Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Non-Invasive Prenatal Testing Devices Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Panorama Test

    • 4.3.2 MaterniT21 Plus Test

    • 4.3.3 Harmony Test

    • 4.3.4 NIFTY Test

    • 4.3.5 Verifi Test

    • 4.3.6 IONA Test

    • 4.3.7 Prena Test

    • 4.3.8 Veracity Test

5 Non-Invasive Prenatal Testing Devices Market: Product Analysis

  • 5.1 Non-Invasive Prenatal Testing Devices Product Market Share Analysis, 2018 & 2026

  • 5.2 Non-Invasive Prenatal Testing Devices Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Non-Invasive Prenatal Testing Devices Market: Application Analysis

  • 6.1 Non-Invasive Prenatal Testing Devices Application Market Share Analysis, 2018 & 2026

  • 6.2 Non-Invasive Prenatal Testing Devices Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals

    • 6.3.2 Clinics

    • 6.3.3 Research Laboratories

7 Non-Invasive Prenatal Testing Devices Market: Regional Analysis

  • 7.1 Non-Invasive Prenatal Testing Devices Regional Market Share Analysis, 2018 & 2026

  • 7.2 Non-Invasive Prenatal Testing Devices Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Safembryo

    • 9.1.1 Safembryo Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Beijing Genomics Institute

    • 9.2.1 Beijing Genomics Institute Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 PerkinElmer, Inc

    • 9.3.1 PerkinElmer, Inc Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 NIPD Genetics

    • 9.4.1 NIPD Genetics Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Laboratory Corporation of America Holdings

    • 9.5.1 Laboratory Corporation of America Holdings Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 California, Inc

    • 9.6.1 California, Inc Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 GE Healthcare

    • 9.7.1 GE Healthcare Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Ariosa Diagnostics (Roche)

    • 9.8.1 Ariosa Diagnostics (Roche) Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Natera

    • 9.9.1 Natera Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 LifeLabs Genetics

    • 9.10.1 LifeLabs Genetics Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Berry Genomics

    • 9.11.1 Berry Genomics Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Illumina, Inc

    • 9.12.1 Illumina, Inc Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Agilent Technologies, Inc

    • 9.13.1 Agilent Technologies, Inc Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Genpharm Services

    • 9.14.1 Genpharm Services Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Quest Diagnostics

    • 9.15.1 Quest Diagnostics Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 LifeCodexx AG

    • 9.16.1 LifeCodexx AG Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 F. Hoffmann-La Roche

    • 9.17.1 F. Hoffmann-La Roche Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 QIAGEN N.V

    • 9.18.1 QIAGEN N.V Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Sengenics

    • 9.19.1 Sengenics Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Koninklijke Philips N.V

    • 9.20.1 Koninklijke Philips N.V Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Premaitha Health PLC

    • 9.21.1 Premaitha Health PLC Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

  • 9.22 Sequenom

    • 9.22.1 Sequenom Company overview

    • 9.22.2 Financial performance

    • 9.22.3 Product benchmarking

    • 9.22.4 Strategic initiatives

    • 9.22.5 SWOT analysis

  • 9.23 Thermo Fisher Scientific, Inc

    • 9.23.1 Thermo Fisher Scientific, Inc Company overview

    • 9.23.2 Financial performance

    • 9.23.3 Product benchmarking

    • 9.23.4 Strategic initiatives

    • 9.23.5 SWOT analysis

  • 9.24 CombiMatrix

    • 9.24.1 CombiMatrix Company overview

    • 9.24.2 Financial performance

    • 9.24.3 Product benchmarking

    • 9.24.4 Strategic initiatives

    • 9.24.5 SWOT analysis

 

The List of Tables and Figures (Totals 72 Figures and 148 Tables)

  • Figure Panorama Test Non-Invasive Prenatal Testing Devices market, 2015 - 2026 (USD Million)

  • Figure MaterniT21 Plus Test Non-Invasive Prenatal Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Harmony Test Non-Invasive Prenatal Testing Devices market, 2015 - 2026 (USD Million)

  • Figure NIFTY Test Non-Invasive Prenatal Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Verifi Test Non-Invasive Prenatal Testing Devices market, 2015 - 2026 (USD Million)

  • Figure IONA Test Non-Invasive Prenatal Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Prena Test Non-Invasive Prenatal Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Veracity Test Non-Invasive Prenatal Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Clinics market, 2015 - 2026 (USD Million)

  • Figure Research Laboratories market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Non-Invasive Prenatal Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table North America Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table North America Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table North America Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Canada Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Canada Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Europe Non-Invasive Prenatal Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table Europe Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Europe Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Europe Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Germany Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Germany Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table France Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table France Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Italy Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Italy Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Spain Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Spain Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Non-Invasive Prenatal Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table China Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table China Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Japan Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Japan Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table India Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table India Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Non-Invasive Prenatal Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table MEA Non-Invasive Prenatal Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table MEA Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table MEA Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table MEA Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Non-Invasive Prenatal Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Non-Invasive Prenatal Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Non-Invasive Prenatal Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Safembryo Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beijing Genomics Institute Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PerkinElmer, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table NIPD Genetics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Laboratory Corporation of America Holdings Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table California, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ariosa Diagnostics (Roche) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Natera Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table LifeLabs Genetics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Berry Genomics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Illumina, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Agilent Technologies, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Genpharm Services Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Quest Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table LifeCodexx AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F. Hoffmann-La Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table QIAGEN N.V Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sengenics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Koninklijke Philips N.V Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Premaitha Health PLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sequenom Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermo Fisher Scientific, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CombiMatrix Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top